Title : NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation.

Pub. Date : 2017 Mar

PMID : 28130034






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 NICE guidance on ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia in the presence of 17p deletion or TP53 mutation. ibrutinib tumor protein p53 Homo sapiens